Loading patent…
AssigneeAccess Business Group International LLC
InventorsGopi Menon, David Fast, Lisa Rozga, Yumei Lin
Estimating the term…
An composition and related method that prevents, inhibits and/or mitigates an allergic response by down regulating the production of IgE, down regulating the binding of IgE antibodies to receptors on cells, and/or inhibiting allergy mediators, for example, histamine, prostoglandin D2, or luekotriene C4 release. The composition comprises at least one of the following ingredients: luteolin from Perilla leaf or seed, Cinnamon, Kiwi, Picao preto, Hesperidin, Acerola cherry, Guaco, Holy Basil, Kakadu, Solamum, Rosmarinic acid, Tinospora and Aframomum. In one embodiment, the composition at least three different ingredients selected from Cinnamon, Acerola, Luteolin and Picao preto. Optionally, these ingredients can be combined with at least one of Aframomum, Rosmarinic acid, and Tinospora. The composition is administered with effective amounts to prevent, inhibit and/or mitigate allergic responses.
A method for inhibiting an allergic response in a human subject comprising orally administering to the human subject an effective amount of a composition including a Cinnamon ingredient in an amount of about 25 mg to about 650 mg, an Acerola ingredient in an amount of about 25 mg to about 650 mg, and a Picao preto ingredient in an amount of about 25 mg to about 650 mg, wherein the ingredients operate to at least one of down-regulate IgE expression, inhibit IgE secretion and inhibit an allergy mediator.
A method for inhibiting allergic symptoms expressed by a subject comprising administering an effective amount of a composition, which comprises a Cinnamon ingredient, an Acerola ingredient, and a Picao preto ingredient, to the subject.
A method for treating an allergic response comprising administering an effective amount of a composition including a Cinnamon ingredient, an Acerola ingredient, and a Picao preto ingredient, to a subject in need thereof.
Dependencies are inferred from the claim text.